SNIP1 mutations in the FHA domain affect cell viability and pre-mRNA splicing To determine whether mutations in the SNIP1 FHA domain affect incorporation of SNIP1 into the activated spliceosome, we expressed flag-tagged SNIP1 (F-SNIP1) WT, single mutants K265G, K301G, R365G, E366G, and the double mutant K265G/K301G in cells and compared their association with components of the activated spliceosome (Fig
3i) or plasma and tissue PAGly levels (Supplementary Fig
GMP Quality Assured
The company employs a chief legal officer with decades of healthcare law experience, both at Google and at a private firm where she represented digital health companies, hospitals, health systems and other healthcare and life sciences companies
Weighing in on obesity and psoriatic arthritis - time to move beyond association to robust randomised trials
qRT-PCR was performed as previously reported[14]